Alternative splicing in neurodegenerative disease and the promise of RNA therapies

被引:60
作者
Nikom, David [1 ,2 ]
Zheng, Sika [1 ,2 ,3 ]
机构
[1] Univ Calif Riverside, Neurosci Grad Program, Riverside, CA 92521 USA
[2] Univ Calif Riverside, Ctr RNA Biol & Med, Riverside, CA 92521 USA
[3] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA
基金
美国国家卫生研究院;
关键词
AMYLOID PRECURSOR PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; NEURITIC PLAQUE DENSITY; ALZHEIMERS-DISEASE; MESSENGER-RNA; ALPHA-SYNUCLEIN; TAU EXON-10; APOLIPOPROTEIN-E; MYOTONIC-DYSTROPHY; INHIBITOR DOMAIN;
D O I
10.1038/s41583-023-00717-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alternative splicing dysregulation contributes to the molecular pathology of a wide range of neurodegenerative diseases. In this Review, Nikom and Zheng discuss the latest advances in RNA-based therapeutic strategies developed to target the underlying splicing mechanisms. Alternative splicing generates a myriad of RNA products and protein isoforms of different functions from a single gene. Dysregulated alternative splicing has emerged as a new mechanism broadly implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer disease, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson disease and repeat expansion diseases. Understanding the mechanisms and functional outcomes of abnormal splicing in neurological disorders is vital in developing effective therapies to treat mis-splicing pathology. In this Review, we discuss emerging research and evidence of the roles of alternative splicing defects in major neurodegenerative diseases and summarize the latest advances in RNA-based therapeutic strategies to target these disorders.
引用
收藏
页码:457 / 473
页数:17
相关论文
共 50 条
  • [41] The potential of epigenetic therapies in neurodegenerative diseases
    Coppede, Fabio
    FRONTIERS IN GENETICS, 2014, 5
  • [42] TGM2 and implications for human disease: role of alternative splicing
    Lai, Thung-S.
    Greenberg, Charles S.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 504 - 519
  • [43] Alternative Splicing of STAT3 Is Affected by RNA Editing
    Goldberg, Lior
    Abutbul-Amitai, Mor
    Paret, Gideon
    Nevo-Caspi, Yael
    DNA AND CELL BIOLOGY, 2017, 36 (05) : 367 - 376
  • [44] Alternative platelet activation pathways and their role in neurodegenerative diseases
    Ferrer-Raventos, Paula
    Beyer, Katrin
    NEUROBIOLOGY OF DISEASE, 2021, 159
  • [45] Stem Cell Therapies for Neurodegenerative Diseases
    Sugaya, Kiminobu
    Vaidya, Manjusha
    EXOSOMES, STEM CELLS AND MICRORNA: AGING, CANCER AND AGE RELATED DISORDERS, 2018, 1056 : 61 - 84
  • [46] Autophagy regulation by RNA alternative splicing and implications in human diseases
    Gonzalez-Rodriguez, Patricia
    Klionsky, Daniel J.
    Joseph, Bertrand
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] miRNA-Based Regulation of Alternative RNA Splicing in Metazoans
    Schorr, Anna L.
    Mangone, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [48] Protein transmission in neurodegenerative disease
    Peng, Chao
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    NATURE REVIEWS NEUROLOGY, 2020, 16 (04) : 199 - 212
  • [49] Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases
    Chopra, Gouri
    Shabir, Shabnam
    Yousuf, Sumaira
    Kauts, Simran
    Bhat, Shahnawaz A.
    Mir, Ashiq H.
    Singh, Mahendra P.
    MOLECULAR NEUROBIOLOGY, 2022, 59 (12) : 7513 - 7540
  • [50] RNA-binding proteins implicated in neurodegenerative diseases
    Cookson, Mark R.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2017, 8 (01)